Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur l'Indium

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Le cluster Time Factors - Tumor Cells, Cultured

Terms

19Time Factors
10Tumor Cells, Cultured
10Kinetics
9Radioimmunotherapy

Associations

Freq.WeightAssociation
44Kinetics - Tumor Cells, Cultured
33Radioimmunotherapy - Tumor Cells, Cultured
33Kinetics - Time Factors
Documents par ordre de pertinence
000313 (????) Indium-111 labeling of low density lipoproteins with the DTPA-bis(stearylamide): evaluation as a potential radiopharmaceutical for tumor localization.
000315 (????) Improved tumor selectivity of radiolabeled peptides by receptor and antigen dual targeting in the neurotensin receptor model.
000317 (????) Enhanced targeting specificity to tumor cells by simultaneous recognition of two antigens.
000139 (2002) Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft.
000208 (1996) Comparative targeting of human colon-carcinoma multicell spheroids using one- and two-step (bispecific antibody) techniques.
000218 (1995) Fate of mouse macrophages radiolabelled with PKH-95 and injected intravenously.
000254 (1992) Use of multi-cell spheroids of ovarian carcinoma as an intraperitoneal radio-immunotherapy model: uptake, retention kinetics and dosimetric evaluation.
000263 (1991) The site of platelet destruction in thrombocytopenic purpura as a predictive index of the efficacy of splenectomy.
000309 (????) Synthesis of new bivalent peptides for applications in the Affinity Enhancement System.
000007 (2013) Sustained therapeutic perfusion outside transplanted sites in chronic myocardial infarction after stem cell transplantation.
000017 (2012) Visualisation of sentinel lymph node with indium-based near infrared emitting Quantum Dots in a murine metastatic breast cancer model.
000022 (2012) Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC).
000032 (2011) Time-resolved UV-visible spectroelectrochemistry using transparent 3D-mesoporous nanocrystalline ITO electrodes.
000033 (2011) Surface reactivity from electrochemical lithography: illustration in the steady-state reductive etching of perfluorinated surfaces.
000074 (2008) Simultaneous dual-band ultra-high resolution full-field optical coherence tomography.
000091 (2007) Doubly radiolabeled liposomes for pretargeted radioimmunotherapy.
000111 (2005) Octreotide (long-acting release formulation) treatment in patients with graves' orbitopathy: clinical results of a four-month, randomized, placebo-controlled, double-blind study.
000120 (2004) Tumour-derived and host-derived nitric oxide differentially regulate breast carcinoma metastasis to the lungs.
000129 (2003) Pharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial.
000131 (2003) Misdiagnosis of chronic thrombocytopenia in childhood.
000160 (1999) Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections.
000162 (1999) Somatostatin receptor scintigraphy to predict the clinical evolution and therapeutic response of thyroid-associated ophthalmopathy.
000163 (1999) Somatostatin receptor scintigraphy in pituitary adenomas: a somatostatin receptor density index can predict hormonal and tumoral efficacy of octreotide in vivo.
000164 (1999) Increased adhesion of the promyelocytic leukaemia cell line, NB4, to fibronectin and thrombospondin upon all-trans-retinoic acid treatment.
000166 (1999) Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody.
000187 (1997) Therapy for colon carcinoma xenografts with bispecific antibody-targeted, iodine-131-labeled bivalent hapten.
000222 (1995) Bifunctional antibodies for radioimmunotherapy.
000257 (1992) Influence of a preadsorbed terpolymer on human platelet accumulation, fibrinogen adsorption, and ex vivo blood activation in hemodialysis hollow fibers.
000268 (1991) Phase I study of liposomal MTP-PE-activated autologous monocytes administered intraperitoneally to patients with peritoneal carcinomatosis.
000269 (1991) Imaging of myocardial infarction in dogs and humans using monoclonal antibodies specific for human myosin heavy chains.
000276 (1990) Scintigraphic assessment of indium-111-labeled granulocyte splenic pooling: a new approach to inflammatory bowel disease activity.
000280 (1990) Lung function declines in patients with pulmonary sarcoidosis and increased respiratory epithelial permeability to 99mTc-DTPA.
000293 (1989) Biodistribution of indium-111-labeled OC 125 monoclonal antibody after intraperitoneal injection in nude mice intraperitoneally grafted with ovarian carcinoma.
000297 (1988) Pulmonary clearance of three aerosolized solutes in oleic acid-induced lung injury.
000303 (1987) Platelet kinetics in stable asthmatic patients.
000311 (????) Preliminary study of the metal binding site of an anti-DTPA-indium antibody by equilibrium binding immunoassays and immobilized metal ion affinity chromatography.
Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024